Baxter International Sells Kidney Care to Carlyle Group
Company Announcements

Baxter International Sells Kidney Care to Carlyle Group

Baxter International ( (BAX) ) has provided an update.

Baxter International Inc. announced a strategic decision to sell its Kidney Care business to affiliates of Carlyle Group Inc., classifying it as a discontinued operation starting in Q3 2024. This move, pending regulatory approvals, aims to streamline Baxter’s financial presentation, impacting how past financials are reported. The change is designed to help investors better analyze Baxter’s ongoing operations, aligning with its strategy to focus on core business areas.

See more insights into BAX stock on TipRanks’ Stock Analysis page.

Related Articles
Jason CarrBaxter International Inc (BAX) Q3 Earnings Cheat Sheet
TheFlyICU Medical initiated with a Hold at Jefferies
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App